A trusted leader advancing the industry through science

Emerald Health Sciences has launched or acquired companies worldwide that are leading the way in developing innovative pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system. Each company within our portfolio leverages the scientific rigor and life-science expertise of our leadership.

Read More

Our portfolio spans continents and sectors

Portfolio Map
Emerald Health Group of Companies

Our Portfolio

As a part of our commitment, we work in partnership with each of our companies to provide knowledge, skill and resources to ensure their success and growth as pioneers in their respective cannabis industry sectors – cultivation, consumer products, research and development, pharmaceuticals and analytical testing. Together we are the Emerald Group of Companies, and through our combined success our aim is to enhance the health of others through innovation in cannabis science.

Featured News

Feds helping Canadian cannabis firms grow their businesses

November 4, 2018

Future of Legal Marijuana: Canadian Greenhouses Could Mean Cheaper, Safer Pot

The red-leafed blueberry bushes and greenhouses filled with tomatoes tell you that this small town south of Vancouver is a great place to grow things. [read more]

Realizing the Full Potential of Recreational Cannabis Legislation in Canada

November 14, 2018

Cannabis Vaping Laws Frustrate B.C. Entrepreneurs

Canada’s rules around cannabis vaping are frustrating entrepreneurs and putting consumers’ health at risk, according to those in the industry. [read more]

10 Canadian Marijuana Stocks for Your Portfolio

October 8, 2018

Developing Cannabinoid Derivative EHP-101 for Multiple Sclerosis

With a phase I trial of the therapy underway, EHP-101 is one step closer to potentially showing an effect on the pathology of multiple sclerosis. [read more]

Emerald Newsletter

Sign up today and receive all of Emerald’s latest news and events directly to your inbox.